Source: Eur Respir J 2012; 40: 269-270
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Frank Rebecca C., Hicks Sophie, Duck Annette M., Spencer Lisa, Leonard Colm T., Barnett Emma. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit?. Eur Respir J 2012; 40: 269-270

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary emphysema and idiopathic pulmonary fibrosis: Is the pattern of exercise-induced oxygen desaturation same or different? Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Source: Breathe 2016; 12: 130-138 Year: 2016 Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 Home spirometry for idiopathic pulmonary fibrosis: ready for prime time? Source: Eur Respir J, 50 (1) 1701403; 10.1183/13993003.01403-2017 Year: 2017 Contribution of home pulmonary rehabilitation in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008 Benefits of pulmonary rehabilitation and predictor of changes in exercise capacity for idiopathic pulmonary fibrosis Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014 Pulmonary rehabilitation in idiopathic pulmonary fibrosis: Predictors of adherence and exercise improvement Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 The contributing factors to mean pulmonary artery pressure in idiopathic pulmonary fibrosis Source: International Congress 2016 – Latest insights into chronic care Year: 2016 Communicating with patients with idiopathic pulmonary fibrosis: can we do it better? Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021 Year: 2022 Ambulatory oxygen in interstitial lung disease Source: Eur Respir J 2011; 38: 987-990 Year: 2011 Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Severe idiopathic pulmonary fibrosis: what can be done? Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017 Year: 2017 Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis Source: ERJ Open Res, 7 (3) 00321-2021; 10.1183/23120541.00321-2021 Year: 2021 The therapy of idiopathic pulmonary fibrosis: what is next? Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019 Year: 2019 Inspiration plus: baseline characteristics of the canadian registry for IPF patients on pirfenidone Source: International Congress 2016 – Orphan diseases II Year: 2016 IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK Source: International Congress 2015 – Latest insights into chronic care Year: 2015